Agenus Inc., a medical-stage biotechnology business, discovers and develops therapies to activate your body's immune program in opposition to most cancers and bacterial infections in the United States and internationally. It provides Retrocyte Display, an antibody expression platform to the identification of completely human and humanized monoclona